Stefan Seewald
Appearances
- DateMay 9, 2023Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…
Presenter
Speakers
Westmead hospital, University of SydneyUniversitatsklinikum Augsburg - DateMay 9, 2023For training deep learning algorithms in medical imaging, application-specific data is often scarce…
Speakers
Presenter
- DateMay 8, 2023BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
Speakers
Presenter
- DateMay 21, 2024Optimal management following radical endoscopic resection (R0 ER) of T1 esophageal adenocarcinoma (EAC) is still a matter of debate due to conflicting reports on the risk for lymph node metastases (LNM). In case of histological risk factors for LNM, i.e…
Presenter
Speakers
Westmead hospital, University of SydneyCleveland Clinic London
